Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01847209 |
Recruitment Status :
Completed
First Posted : May 6, 2013
Results First Posted : April 29, 2019
Last Update Posted : April 29, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Lung Cancer | Procedure: Video-Assisted Thoracic Surgery (VATS) wedge resection | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 25 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Percutaneous Image Guided Video Assisted Thoracic Surgery (VATS) Resection of Lung Lesions |
Study Start Date : | April 2013 |
Actual Primary Completion Date : | September 2014 |
Actual Study Completion Date : | December 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: CT Marking and VATS lung wedge resection
Each patient with a lung nodule meeting criteria will undergo marking with fiducials followed at the same time by Video-Assisted Thoracic Surgery (VATS) lung wedge resection under CT fluoroscopy.
|
Procedure: Video-Assisted Thoracic Surgery (VATS) wedge resection
Other Name: Nodules marked with fiducials such as Kopan needles under CT fluoroscopy followed by VATS wedge resection. |
- Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 [ Time Frame: 30 days ]The patient will be monitored while in the hospital by their thoracic surgical team as well as by two research nurses named Lauren Donahue, RN and Karen Magsipoc, NP. The research nurses will document any perioperative complications and mortality that arise during the patient's stay in the hospital.
- Patients Underwent a Successful Resection [ Time Frame: 30 days ]Number of patients who underwent a successful resection which is measured by an accurate and appropriate resection in a given timeline

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- peripheral lung nodules < 3cm in size
- Surgical candidate
Exclusion Criteria:
- Non surgical candidate

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01847209
United States, Massachusetts | |
Brigham and Women's Hospital | |
Boston, Massachusetts, United States, 02115 |
Principal Investigator: | Raphael Bueno, M.D. | Brigham and Women's Hospital |
Responsible Party: | Raphael Bueno, Associate Chief of Thoracic Surgery; Professor of Surgery, Brigham and Women's Hospital |
ClinicalTrials.gov Identifier: | NCT01847209 |
Other Study ID Numbers: |
2012P001915 |
First Posted: | May 6, 2013 Key Record Dates |
Results First Posted: | April 29, 2019 |
Last Update Posted: | April 29, 2019 |
Last Verified: | January 2019 |
lung nodule lung cancer lung mass |
Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases |